Studies have shown that AMPK activation suppresses proliferation of a variety of tumor cells as well as nonmalignant cells, which indicates that activation of AMPK is a promising strategy for the treatment of cancer as well as other human diseases [14,15,16]. The gene discussed is PRKAA1; the disease is cancer.